Skip to main content
. Author manuscript; available in PMC: 2018 Apr 2.
Published in final edited form as: J Appl Clin Med Phys. 2017 Jun 2;18(4):84–96. doi: 10.1002/acm2.12100

Table 5.

Dosimetric parameters of all ten virtual simulated VMAT plans D 95: the minimal dose to 95% of the PTV, D5: minimal dose to 5% of the PTV, Dmean: mean dose to the PTV, CI: conformal index, the ratio between PTV and volume receiving dose larger than prescription dose, HI: homogeneity index, the difference between D5 and D95, divided by Dmean.

Clinically treated plan pt 1 pt 2 pt 3 pt 4 pt 5 pt 6 pt 7 pt 8 pt 9 pt 10 mean sd
D95 [cGy] 3295 3305 3092 3075 2960 3150 3307 3153 3301 3037 3168 121
Dmean [cGy] 3776 3729 3840 3780 3803 3855 3629 3756 3831 3813 3781 63
V33 [%] 94.9 95.1 91.1 90.0 90.0 93.0 95.2 92.6 95.0 91.0 92.8 2.0
volume of 33Gy + [cc] 36.7 123.5 94.9 79.4 111.5 57.9 60.4 120.8 48.5 100.1 83.4 29.7
volume of PTV [cc] 29.7 117.2 86.9 81.2 104.1 50.1 57.4 115.0 44.3 95.8 78.2 29.4
CI [ratio] 1.23 1.05 1.09 0.98 1.07 1.16 1.05 1.05 1.09 1.05 1.08 0.07
D5 [cGy] 4028 4112 4167 4201 4215 4222 3797 4091 4182 4208 4122 124
HI [ratio] 0.19 0.22 0.28 0.30 0.33 0.28 0.14 0.25 0.23 0.31 0.25 0.06